AXL is involved in the development of fibrosis, linking AXL with non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC) [89]. This evidence concerns the gene AXL and metabolic dysfunction-associated steatohepatitis.